A STUDY OF THE CHARACTERISTICS OF THE RAT PLACENTAL IODOTHYRONINE 5-MONODEIODINASE - EVIDENCE THAT IT IS DISTINCT FROM THE RAT HEPATIC IODOTHYRONINE 5'-MONODEIODINASE
F. Santini et al., A STUDY OF THE CHARACTERISTICS OF THE RAT PLACENTAL IODOTHYRONINE 5-MONODEIODINASE - EVIDENCE THAT IT IS DISTINCT FROM THE RAT HEPATIC IODOTHYRONINE 5'-MONODEIODINASE, Endocrinology, 130(4), 1992, pp. 2325-2332
Recent studies have demonstrated that rat liver type I iodothyronine 5
'-monodeiodinase (5'-MD) characteristically contains selenocysteine. T
he present study was undertaken to characterize rat placental type III
iodothyronine 5-MD and to compare it with 5'-MD. Solubilized rat plac
ental microsomes were delipidated by carboxymethyl cellulose-Sephadex
chromatography. Phospholipids and proteins were recovered in two disti
nct peaks, which did not show 5-MD activity. 5-MD activity was recover
ed fully, however, by combining the two components (phospholipids and
protein) and partially after the addition of exogenous phospholipids t
o protein. Tissue selenoproteins were labeled by injection of radioact
ive selenium (Se-75; 50-mu-Ci, iv; on days 5, 10, and 15 of gestation)
to pregnant rats. Subcellular fractions of maternal and fetal tissues
were resolved by sodium dodecyl sulfate-polyacrylamide gel electropho
resis, followed by autoradiography. No specific seleno-labeled protein
s were evident in the microsomes of placenta or maternal or fetal brai
n. A 27- to 29-kilodalton (kDa) band previously suggested to be 5'-MD
was observed, however, in maternal liver and kidney microsomes. Auroth
ioglucose inhibited rat placental 5-MD, but the dose required for 50%
inhibition was over 50-fold greater than that for Se-containing hepati
c 5'-MD (430 vs. 8 nM). The mechanism of the inhibition was noncompeti
tive for 5-MD, whereas it was competitive for 5'-MD. A synthetic pepti
de of 16 amino acids corresponding to the carboxy-terminal portion of
5'-MD was synthesized, and rabbits were immunized with the peptide-BSA
conjugate. Western blot studies using the rabbit antiserum showed one
specific 29-kDa band in rat liver microsomes. However, no specific ba
nds were observed in 5-MD-rich placental or fetal brain microsomes. Br
omoacetyl T3 (BrAcT3) was a potent inhibitor of rat placental 5-MD. Af
finity labeling of solubilized rat placental microsomes with [I-125]Br
AcT3 showed a predominant band of 31 kDa, distinct from the 27- to 29-
kDa band found in liver and kidney. The labeling of the 31-kDa band wa
s enhanced by 10 mM dithiothreitol, inhibited 60% by 150-mu-M T3, and
prevented by 40-mu-M aurothioglucose. A dominant affinity-labeled 31-k
Da band was also observed in fetal brain microsomes. Some tissues with
out 5-MD activity (testes and spleen) also showed weak binding. We con
clude that rat placental 5-MD 1) requires phospholipids for enzymatic
activity, 2) is not a seleno-containing enzyme, and 3) differs from th
e 27- to 29-kDa hepatic 5'-MD in the carboxy-terminal portion of the m
olecule. The 31-kDa protein labeled with [I-125]BrAcT3 may be the subs
trate-binding subunit of 5-MD. The presence of a similar, albeit weak,
affinity-labeled band in some inactive tissues may signify that multi
ple subunits are required for 5-MD activity.